Coumanolignan

Details

Top
Internal ID 98207712-87be-4993-88f9-c75a2f1187e8
Taxonomy Phenylpropanoids and polyketides > Coumarins and derivatives
IUPAC Name 8-(2-hydroxy-5-prop-2-enylphenyl)-6-prop-2-enylchromen-2-one
SMILES (Canonical) C=CCC1=CC(=C(C=C1)O)C2=C3C(=CC(=C2)CC=C)C=CC(=O)O3
SMILES (Isomeric) C=CCC1=CC(=C(C=C1)O)C2=C3C(=CC(=C2)CC=C)C=CC(=O)O3
InChI InChI=1S/C21H18O3/c1-3-5-14-7-9-19(22)17(12-14)18-13-15(6-4-2)11-16-8-10-20(23)24-21(16)18/h3-4,7-13,22H,1-2,5-6H2
InChI Key ZVUXKRKDLKXWJI-UHFFFAOYSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C21H18O3
Molecular Weight 318.40 g/mol
Exact Mass 318.125594432 g/mol
Topological Polar Surface Area (TPSA) 46.50 Ų
XlogP 5.30
Atomic LogP (AlogP) 4.62
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 5

Synonyms

Top
SCHEMBL18838052
8-(2-hydroxy-5-prop-2-enylphenyl)-6-prop-2-enylchromen-2-one

2D Structure

Top
2D Structure of Coumanolignan

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9943 99.43%
Caco-2 - 0.7379 73.79%
Blood Brain Barrier - 0.7500 75.00%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Mitochondria 0.6509 65.09%
OATP2B1 inhibitior - 0.7150 71.50%
OATP1B1 inhibitior + 0.8261 82.61%
OATP1B3 inhibitior + 0.9142 91.42%
MATE1 inhibitior - 0.8000 80.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior + 0.7316 73.16%
P-glycoprotein inhibitior - 0.5255 52.55%
P-glycoprotein substrate - 0.9096 90.96%
CYP3A4 substrate - 0.5935 59.35%
CYP2C9 substrate - 0.5984 59.84%
CYP2D6 substrate - 0.8039 80.39%
CYP3A4 inhibition - 0.6845 68.45%
CYP2C9 inhibition + 0.8458 84.58%
CYP2C19 inhibition - 0.5368 53.68%
CYP2D6 inhibition - 0.9063 90.63%
CYP1A2 inhibition - 0.8649 86.49%
CYP2C8 inhibition + 0.5372 53.72%
CYP inhibitory promiscuity + 0.5211 52.11%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9313 93.13%
Carcinogenicity (trinary) Non-required 0.5735 57.35%
Eye corrosion - 0.9840 98.40%
Eye irritation - 0.6655 66.55%
Skin irritation + 0.5725 57.25%
Skin corrosion - 0.9717 97.17%
Ames mutagenesis - 0.5400 54.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5410 54.10%
Micronuclear + 0.7659 76.59%
Hepatotoxicity + 0.7375 73.75%
skin sensitisation - 0.6366 63.66%
Respiratory toxicity - 0.5778 57.78%
Reproductive toxicity + 0.7778 77.78%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity - 0.7639 76.39%
Acute Oral Toxicity (c) II 0.5873 58.73%
Estrogen receptor binding + 0.7184 71.84%
Androgen receptor binding + 0.8481 84.81%
Thyroid receptor binding + 0.6326 63.26%
Glucocorticoid receptor binding + 0.8456 84.56%
Aromatase binding + 0.8102 81.02%
PPAR gamma + 0.9520 95.20%
Honey bee toxicity - 0.8214 82.14%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.5900 59.00%
Fish aquatic toxicity + 0.9926 99.26%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1951 P21397 Monoamine oxidase A 95.32% 91.49%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.17% 91.11%
CHEMBL2581 P07339 Cathepsin D 94.67% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.38% 95.56%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 86.62% 96.95%
CHEMBL3492 P49721 Proteasome Macropain subunit 86.60% 90.24%
CHEMBL3401 O75469 Pregnane X receptor 86.49% 94.73%
CHEMBL1293267 Q9HC97 G-protein coupled receptor 35 86.20% 89.34%
CHEMBL3060 Q9Y345 Glycine transporter 2 85.49% 99.17%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 84.41% 94.00%
CHEMBL4530 P00488 Coagulation factor XIII 83.64% 96.00%
CHEMBL2085 P14174 Macrophage migration inhibitory factor 83.53% 80.78%
CHEMBL2553 Q15418 Ribosomal protein S6 kinase alpha 1 82.37% 85.11%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 81.33% 90.71%
CHEMBL3194 P02766 Transthyretin 80.97% 90.71%

Cross-Links

Top
PubChem 24796112
NPASS NPC105004
LOTUS LTS0118224
wikiData Q105384678